Education + Advocacy = Change

Click a topic below for an index of articles:

New Material




Alternative Treatments

Financial or Socio-Economic Issues

Health Insurance

Help us Win the Fight



Institutional Issues

International Reports

Legal Concerns

Math Models or Methods to Predict Trends

Medical Issues

Our Sponsors


Occupational Concerns


Religion and infectious diseases

State Governments

Stigma or Discrimination Issues

If you would like to submit an article to this website, email us your paper to



any words all words

Results per page:


“The only thing necessary for these diseases to the triumph is for good people and governments to do nothing.”



Main topics can be found within the left column; sub-topics and/or research reports can be found near the bottom of this page.  Thank you

We offer a monthly newsletter dealing with the various issues surrounding infectious diseases.  To find out more click HERE.


In today's world, we are faced with soaring healthcare costs, and concurrently tighter budgetary controls on medical allowances, and research and education monies; our first duty is to help those afflicted to recover to the greatest extent possible, and to help them in understanding their disease, its management, and how to achieve the highest quality of life possible. Commensurate with this needs to be the ongoing funding and cost management objectives requisite to invest in making headway in getting one-step ahead of the disease for the salvation of our children, and hence, our collective future.

As the demand for healthcare increases, the basic resources of medicine will be strained. The costs associated with medicine have increased and access has decrease, not only for those who are positive but also for individuals with other health problems.

Because of the demand for coverage, the medical professions are currently experiencing a major shortage of medical professionals, from Doctors to medical technicians. This scarcity of professionals will continue to increase over time as these professionals seek better paying jobs, better working conditions, or just drop out of this profession.

Those countries with National Health Insurance have seen their costs increase; and for the citizens of those countries, they have seen their taxes increase to cover these increased costs.

In the United States, the employer has largely paid for Health Insurance as a perk for being an employee. Those companies are now passing those increases on to their employees. Many of these employees have discontinued their respective health insurance coverage because they simply cannot afford these increases. American businesses have had their profit margins squeezed by the rising costs of healthcare.


Document Name & Link to Document


File Type/Size **

$3 Trillion in US Health Spending is Projected

 $3 Trillion in US Health Spending is Projected 28 kb HTML Healthcare spending will top $2.8 trillion in the US by 2011, driving an even larger chunk of the nation's gross domestic product (GDP) than previously forecast



Acquired Immunodeficiency Syndrome (AIDS) is currently a growing, worldwide, fatal, pandemic. Destruction of CD4+ T cells predisposes infected individuals to a wide range of opportunistic infections, tumors, dementia and death.  "The reality of AIDS in Botswana is so grim it is hard to grasp. In the main hospital in the capital city, Gaborone, 70% of beds in the pediatric ward are for children with complications of AIDS.

AIDS Diagnosis-based risk adjusters. Insurance Report

PDF / 363KB

Assessing the Value of American Investment in Medical Research Assess the Value of American Investment in Medical Research 33 kb HTML How does a venture capitalist decide where to invest his money? He compares the potential for return against the risk, and when the return appears to be significant and the risk isn't too great, he invests. As our country makes decisions about its future investment in medical research, it might apply a similar standard.



COBRA Rules Extending Your Employer-Based Health Insurance


Containing the Costs while maintaining Quality Methods of Insurance Companies to reduce to cost of care


Controversial Hepatitis C Virus-The Case for Selective Treatment Hepatitis C: Natural History and Independent Predictors of Adverse Outcomes


Cost of Hepatitis C Virus in relation to insurance costs Healthcare Cost of Hepatitis C-infected Members in a Managed Care Organization


Direct cost of Needle sticks and Blood exposures Direct cost of needle sticks to At-Risk body fluids-data from 2 hospitals, Journal Article

PDF / 48KB

Disease management Financial & Risk consideration for disease management, Insurance Report

PDF / 211KB

Estimate of future Hepatitis C Virus morbidity, mortality Future Hepatitis C Virus Morbidity, Mortality, and Costs in the US, Journal Article

PDF / 133 KB

Financing & Quality of HIV/AIDS care Medicaid Program Policy Trends: Financing and Quality of HIV Care


Health care exposure. Healthcare workers' risk of exposure and the data collected concerning consequences of exposure

PDF / 471KB

Health Insurer Benefits from Decline in Some Cost Reports improved first-quarter earnings and raises its profits forecast for year, becoming latest health insurer to benefit from nationwide trend of moderating hospital and drug costs.


Health Spending Growing faster than US Economy Federal health economists reported January 8, health expenditures outpaced the growth of the economy


HEALTHCARE WORKERS SORE OVER NEEDLES FDA WON’T BAN A nursing safety expert asked how many hundreds of medical workers need to die from contaminated needle sticks before the agency bans standard needles and syringes that are causing the injuries


HIPPA Portability Description of HIPPA rules and regulations

PDF / 50KB

Insurance Insurance report - Capitation puts the risk of large claims on the providers, there are questions about the best way to structure this change

PDF / 462KB


Insurance claims Physicians & other providers that accept risk through capitation arrangements may need protection against losses in years with higher than expected levels of medical costs-Insurance Report

PDF / 462KB

Insurance privacy issues Administrative Simplification and Privacy Issues for Health Plans-Insurance Report

PDF / 336KB

Insurance-Actuarial aspects of Dread Disease Insurance Report on methods to deal with infectious diseases

PDF / 526KB

Insurance-Hepatitis C Virus-health, law protection. Report on Hepatitis C Virus explaining the potential cost that have an impact on businesses and explaining the unfolding Hepatitis C Virus epidemic

PDF / 417KB

Madison Ave. has growing role in Drug Research Television ads have helped turn some prescription drugs into billion-dollar products, is expanding role in drug development


NEEDLE STICK RISK Hundreds of medical workers become infected with the AIDS or hepatitis viruses from accidental punctures each year


Notifying patients exposed to blood products associated with Creutzfeldt–Jakob disease: integrating science, legal duties and ethical mandates THE ISSUE OF NOTIFYING PEOPLE who have been exposed to blood products that have been associated with Creutzfeldt–Jakob disease (CJD) has arisen at a time when the Canadian blood system is under intense scrutiny. As a result, the Canadian Red Cross Society issued a recommendation to health care institutions that recipients of CJD-associated blood products be identified, notified and counselled. Although Canadian jurisprudence in the realm of informed consent may support a policy of individual notification, a review of the scientific evidence and the applicable ethical principles arguably favours a policy of a more general public notification. Indeed, situations such as this require a unique approach to the formation of legal and ethical duties, one that effectively integrates all relevant factors. As such, the authors argue that individual notification is currently not justified. Nevertheless, if a system of general notification is implemented (e.g., through a series of public health announcements), it should provide, for people who wish to know, the opportunity to find out whether they were given CJD-associated products. Pdf 114 kb
Patients paying larger percentage of Medical Costs Faced with "rapidly rising" prescription drug spending, which is climbing at about 15% per year, employers and insurers have increasingly shifted the costs to patients, who "may soon pay even more,..."


Policy Policy Statements adopted by the Governing Council of the APHA, Nov. 10, 1999

PDF / 486KB

Poor State of Finance in Eastern Africa Direct correlation between GDP growth and financial deepening and penetration


Prescription drug Sales Increased in US Retail prescription drug spending in the US increased for the fifth straight year in 2000


Public Safety Nets Report on how communities and extended families try to cope with difficulties in the absence of government intervention

PDF / 137KB

The Business of Medicine "One of the signs of a cultured society is taking care of its young and its elderly," Dr. Trujillo emphasized. "If we stop taking Medicare, the consequences will be tragic."


The Other Drug War-Public citizen Big Pharma's 625 Washington Lobbyists

PDF / 318KB

The Status and Trends of Infectious Diseases United Nations Report on effect of HIV/AIDS and the affect the disease is having on countries hardest hit with this illness


Tip of  the Iceberg Insurance Report on the Hepatitis C Epidemic and the consequences of the illness

PDF / 445KB

Work related death A continuing epidemic Journal Article concerning occupational exposure to an infectious disease

PDF / 71KB


** In order to view PDF files, you must have Adobe Acrobat Reader installed on your computer. Many computers already have this software; however, if you need it, a free copy is available for download at this site: Click here to get Adobe Acrobat Reader.